KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Accumulated Expenses (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Accumulated Expenses data on record, last reported at $530.1 million in Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 5.58% year-over-year to $530.1 million; the TTM value through Dec 2025 reached $530.1 million, up 5.58%, while the annual FY2025 figure was $530.1 million, 5.58% up from the prior year.
  • Accumulated Expenses reached $530.1 million in Q4 2025 per IDXX's latest filing, up from $488.9 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $541.1 million in Q2 2024 and bottomed at $366.9 million in Q1 2021.
  • Average Accumulated Expenses over 5 years is $447.3 million, with a median of $432.4 million recorded in 2021.
  • Peak YoY movement for Accumulated Expenses: surged 48.43% in 2021, then decreased 22.94% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $458.9 million in 2021, then fell by 5.5% to $433.7 million in 2022, then grew by 10.39% to $478.7 million in 2023, then increased by 4.89% to $502.1 million in 2024, then grew by 5.58% to $530.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $530.1 million in Q4 2025, $488.9 million in Q3 2025, and $417.0 million in Q2 2025.